Pharmacist’s Suspension Lapses After Dishonesty Conviction Review

The GPhC Fitness to Practise Committee reviewed the case of a pharmacist, referred to here as “the registrant,” who had previously been convicted of obtaining exemption from liability by deception in relation to fraudulent business rate relief claims. This review determined whether the registrant’s fitness to practise remained impaired following a period of suspension.

---

Background and Allegations

1. Conviction for Financial Deception (2 September 2021)
   • The registrant, a Managing Director of G Pennant Roberts Limited, was convicted of fraudulently claiming small business rate relief on two pharmacy premises between April 2005 and July 2019.
   • The fraudulent claims resulted in an overpayment of £56,941.75, which the registrant later repaid in full.
2. Criminal Sentencing (20 December 2021)
   • The registrant received a 16-month suspended prison sentence with an 18-month supervision period.
   • Ordered to pay £5,091 in prosecution costs.
3. Previous GPhC Disciplinary Action
   • Initially suspended for four months following a GPhC Fitness to Practise hearing.
   • On 16 January 2024, following an appeal by the Professional Standards Authority (PSA), the High Court increased the suspension to six months with a review.
   • In April 2024, a further three-month suspension was imposed to allow the registrant more time to reflect and remediate.

---

Findings of the Final Review

During the review hearing on 5 July 2024, the Committee considered whether the registrant’s fitness to practise remained impaired.

• Development of Insight
  • The registrant provided written reflections acknowledging the seriousness of their dishonesty and its impact on the pharmacy profession, public confidence, and patient trust.
  • Recognized that the fraudulent claims had diverted public funds and accepted full responsibility.
  • Apologized publicly for their actions and the damage caused to the profession’s reputation.
• Steps Taken to Address Misconduct
  • Completed professional development courses on probity, ethics, insight, reflection, and remediation.
  • Stated they would work closely with an accountant in future financial matters to avoid similar mistakes.
  • Expressed a commitment to upholding GPhC standards and ethical principles moving forward.
• Committee’s Decision
  • The Committee acknowledged the registrant’s progress in understanding the gravity of their misconduct.
  • Concluded that while insight was still developing, the risk of repetition was low.
  • Determined that the registrant’s integrity could now be relied upon.
  • Concluded that public confidence in the profession no longer required continued impairment.

As a result, the Committee ruled that the suspension would lapse upon expiry on 23 July 2024, allowing the registrant to return to pharmacy practice without further restriction.

---

Key Learning Points for Pharmacy Professionals

1. Integrity is Fundamental to the Profession
   • Pharmacists are expected to demonstrate honesty and professionalism in all aspects of their work, including business operations.
2. Fraud and Financial Misconduct Have Serious Consequences
   • Even when unrelated to patient care, financial dishonesty damages public trust in the pharmacy profession.
   • Convictions for fraud can lead to suspension or removal from the GPhC register.
3. Insight and Reflection Are Key to Remediation
   • Demonstrating genuine insight into past misconduct is essential for regaining professional standing.
   • Engaging in continuing professional development (CPD) can support rehabilitation and reinforce ethical behavior.
4. Regulatory Bodies Will Take Action to Protect Public Confidence
   • The GPhC and PSA can appeal disciplinary decisions to ensure appropriate sanctions are applied.
   • Professionals must fully engage with the regulatory process and take active steps toward remediation.